The Kansas City Star: How well do Pfizer COVID vaccines protect kids from hospitalization? CDC has good news
By Katie Camero
Early controlled clinical trials showed the two-dose Pfizer coronavirus vaccine offered strong protection against COVID-19 hospitalization in children, but little has been known about how well the shots work in the real world.
A new study published Oct. 19 by the Centers for Disease Control and Prevention offers more good news.
Research on more than 460 hospitalized people between 12 and 18 years old found that two doses of the Pfizer vaccine were 93% effective against COVID-19 hospitalization during June to September, when the highly infectious delta variant was spreading.
Researchers say their findings show the Pfizer vaccine is extremely effective at preventing hospitalization in kids and young adults. It’s the only vaccine authorized for use in children ages 12 and older as of Oct. 19. Kids are not yet allowed to receive Pfizer booster shots.
Nineteen pediatric hospitals in 16 states were involved in the study, including Children’s Mercy Kansas City in Missouri, University of North Carolina at Chapel Hill Children’s Hospital, Texas Children’s Hospital and Children’s Hospital Los Angeles in California.
Read the full article via The Kansas City Star
For Information About COVID-19